Key facts
- This page summarizes Patrick Soon-Shiong's Form 3 filing for PDS Biotechnology Corp (PDSB).
- 0 reported transactions and 4 derivative rows are listed below.
- Accepted by SEC: 21 Sep 2026, 20:39.
Patrick Soon-Shiong - 14 Sep 2026 Form 3 Insider Report for PDS Biotechnology Corp (PDSB)
- Reporting relationship
- Director, 10%+ Owner
- Issuer ticker
- PDSB
- Reported as of
- 14 Sep 2026
- Net transaction value
- $0
- SEC form
- 3
- Accepted by SEC
- 21 Sep 2026, 20:39:54 UTC
- Prior SEC filing
- 02 Apr 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Patrick Soon-Shiong
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Patrick Soon-Shiong filed Form 3 for PDS Biotechnology Corp (PDSB) on 21 Sep 2026.
Change
- Previous filing in this sequence was filed on 02 Apr 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reporting Owners (2)
CIK 0001189020
Primary reporting owner
SOON-SHIONG PATRICK
- Relationship
- Director, 10%+ Owner
- Address
- C/O PDS BIOTECHNOLOGY CORPORATION, 303A COLLEGE ROAD EAST, PRINCETON
- Signature
- /s/ Patrick Soon-Shiong
- Signature date
- 21 Sep 2026
CIK 0001675758
Nant Capital, LLC
- Relationship
- 10%+ Owner
- Address
- 450 DULEY ROAD, EL SEGUNDO
- Signature
- /s/ Charles Kenworthy, Manager of California Capital Equity and Manager of Nant Capital
- Signature date
- 21 Sep 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
PDSB
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 13,005,334
- Date
- 14 Sep 2026
- Ownership
- See Footnote
- Footnotes
- F1, F2
PDSB
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 13,005,334
- Date
- 14 Sep 2026
- Ownership
- See Footnote
- Footnotes
- F1, F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
PDSB
holding
Derivative
Pre-Funded Warrants
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 14 Sep 2026
- Ownership
- Nant Capital, LLC
- Underlying class
- Common Stock
- Underlying amount
- 22,392,896
- Exercise price
- $0.000300
- Footnotes
- F3, F5
PDSB
holding
Derivative
Pre-Funded Warrants
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 14 Sep 2026
- Ownership
- Nant Capital, LLC
- Underlying class
- Common Stock
- Underlying amount
- 22,392,896
- Exercise price
- $0.000300
- Footnotes
- F3, F5
PDSB
holding
Derivative
Common Warrants
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 14 Sep 2026
- Ownership
- Nant Capital, LLC
- Underlying class
- Common Stock
- Underlying amount
- 17,699,115
- Exercise price
- $0.2200
- Footnotes
- F4, F5
PDSB
holding
Derivative
Common Warrants
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 14 Sep 2026
- Ownership
- Nant Capital, LLC
- Underlying class
- Common Stock
- Underlying amount
- 17,699,115
- Exercise price
- $0.2200
- Footnotes
- F4, F5
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 5 footnotes
Footnote F1
The reported securities are included within 35,398,230 PIPE Units (the "Units") purchased by Nant Capital, LLC ("Nant Capital") from the Issuer for a price of $0.2825 per Unit in a private placement transaction (the "Private Placement") announced on September 7, 2026, which closed on September 14, 2026. Each Unit is comprised of (i) One (1) share of the Issuer's common stock, par value $0.00033 per share ("Common Stock") or, at the election of a purchaser, a Pre-Funded Warrant to purchase one share of Common Stock (the "Pre-Funded Warrant") in lieu of such shares, and (ii) an accompanying Common Warrant to purchase one-half of one share of Common Stock (the "Common Warrant").
Footnote F2
Represents shares of Common Stock purchased directly from the Issuer by Nant Capital in connection with the Private Placement transaction. Dr. Patrick Soon-Shiong is the sole member of Nant Capital and may be deemed to beneficially own the securities held by Nant Capital, subject to any applicable California community property laws.
Footnote F3
The Pre-Funded Warrants are exercisable at any time and have no expiration date. The Pre-Funded Warrants include an exercise limitation that prohibits the holder from exercising the Pre-Funded Warrants in an amount in excess of the specified ownership threshold of 19.9% of the issued and outstanding shares of Common Stock (the "Pre-Funded Warrant Blocker"). Upon 61 days' prior notice to the Issuer, the holder of the Pre-Funded Warrants may increase or decrease the Pre-Funded Warrant Blocker, provided that the Pre-Funded Warrant Blocker in no event exceeds 19.99% of the issued and outstanding shares of Common Stock.
Footnote F4
The Common Warrants are exercisable at any time from the date of issuance through 5:00 p.m., New York City time, on the one-year anniversary of the date of issuance. The Common Warrants include an exercise limitation that prohibits the holder from exercising the Common Warrants in an amount in excess of the specified ownership threshold of 19.9% of the issued and outstanding shares of Common Stock (the "Common Warrant Blocker"). Upon 61 days' prior notice to the Issuer, the holder of the Common Warrants may increase or decrease the Common Warrant Blocker, provided that the Common Warrant Blocker in no event exceeds 19.99% of the issued and outstanding shares of Common Stock
Footnote F5
Dr. Patrick Soon-Shiong is the sole member of Nant Capital and may be deemed to beneficially own the securities held by Nant Capital, subject to any applicable California community property laws.